Dynavax Technologies
DVAX
#5495
Rank
A$1.92 B
Marketcap
A$16.39
Share price
-0.64%
Change (1 day)
-17.58%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : A$0.97 Billion

According to Dynavax Technologies 's latest financial reports the company has A$0.97 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.14 B5.33%
2023-12-31A$1.08 B18.74%
2022-12-31A$0.91 B21.84%
2021-12-31A$0.75 B250.86%
2020-12-31A$0.21 B-0.52%
2019-12-31A$0.21 B4.43%
2018-12-31A$0.20 B-15.93%
2017-12-31A$0.24 B117.58%
2016-12-31A$0.11 B-58.05%
2015-12-31A$0.26 B79.64%
2014-12-31A$0.14 B-29.41%
2013-12-31A$0.21 B76.32%
2012-12-31A$0.12 B8.34%
2011-12-31A$0.11 B56.47%
2010-12-31A$71.03 M73.77%
2009-12-31A$40.87 M-57.88%
2008-12-31A$97.05 M-3.84%
2007-12-31A$0.10 B9.25%
2006-12-31A$92.38 M-10%
2005-12-31A$0.10 B20.64%
2004-12-31A$85.08 M117.36%
2003-12-31A$39.14 M-25.01%
2002-12-31A$52.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
A$5.2 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$5.96 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$27.42 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$11.06 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$12.31 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$6.69 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$22.55 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.31 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$14.21 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA